Arch Capital Group (ACGL)
(Delayed Data from NSDQ)
$111.01 USD
+0.33 (0.30%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $111.04 +0.03 (0.03%) 5:28 PM ET
2-Buy of 5 2
B Value D Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$111.01 USD
+0.33 (0.30%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $111.04 +0.03 (0.03%) 5:28 PM ET
2-Buy of 5 2
B Value D Growth B Momentum B VGM
Zacks News
Top Ranked Momentum Stocks to Buy for May 21st
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 21st.
Top Ranked Momentum Stocks to Buy for May 20th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 20th.
Arch Capital (ACGL) Q1 Earnings Beat, Premiums Rise Y/Y
by Tanuka De
Arch Capital (ACGL) Q1 benefited from improving premiums and net investment income.
Arch Capital Group (ACGL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Arch Capital (ACGL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Hold On to Cboe Global (CBOE) Stock
by Zacks Equity Research
Cboe Global Markets (CBOE) promises return on the back of perational excellence.
Why Should You Add RenaissanceRe (RNR) to Your Portfolio?
by Zacks Equity Research
Riding high on robust premiums and reduced expenses, RenaissanceRe (RNR) holds immense potential to reap benefits for investors.
Here's Why You Should Retain First Essent Group (ESNT) Stock
by Zacks Equity Research
Essent Group (ESNT) promises better rewards on the back of strong mortgage insurance portfolio.
CME Group's (CME) Q1 ADV Down Y/Y, March Volumes Disappoint,
by Zacks Equity Research
CME Group (CME) witnessed lower average daily volumes for both first quarter and March 2019 as volumes declined across all six product line for both the periods.
Here's Why You Should Retain First American (FAF) Stock
by Zacks Equity Research
First American Financial (FAF) promises better return as housing demand improves, coupled with improved rate environment and prudent capital management.
Nasdaq (NDAQ) Completes Divestiture of BWise to SAI Global
by Zacks Equity Research
Nasdaq (NDAQ) sold BWise to consolidate competitive edge in core businesses and maximize opportunities in the capital markets.
RLI Corp Gains 10% in a Year: Will the Upside Continue?
by Zacks Equity Research
Shares of RLI Corp (RLI) is expected to continue the bull run backed by solid fundamentals and initiatives to ramp up growth.
Arch Capital's (ACGL) Reliance on Robust Premiums is a Boon
by Zacks Equity Research
Steady premium growth, intelligent buyouts, expansion of mortgage insurance business and a solid capital position favor Arch Capital (ACGL) to win the trust of yield-seeking investors.
Here's Why You Should Hold on to CME Group (CME) Stock Now
by Zacks Equity Research
CME Group (CME) is poised for growth, given higher clearing and transaction fees, expense management, and strong capital management policy.
Radian Group (RDN) Expands Share Repurchase Authorization
by Zacks Equity Research
The expanded $250 million buyback approval reflects Radian Group's (RDN) solid capital position and effort to enhance shareholders value.
MGIC Investment Board Approves Share Buyback Worth $200M
by Zacks Equity Research
The new $200 million buyback approval reflects MGIC Investment's (MTG) solid capital position and effort to enhance shareholders value.
Here's Why You Hold on to Selective Insurance (SIGI) Now
by Zacks Equity Research
Selective Insurance (SIGI) remains poised for growth on geographic expansion and sturdy capital position.
Progressive's February Earnings and Revenues Increase Y/Y
by Zacks Equity Research
Progressive's (PGR) February results reflect solid policies in force, higher premium as well as surge in investment income.
Arch Capital (ACGL) Up 1.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Arch Capital (ACGL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Health Insurance Up 24% in a Year: Will the Rally Continue?
by Zacks Equity Research
Health Insurance Innovations' (HIIQ) solid fundamentals and favorable industry trends should help the stock continue the bull run.
American Financial (AFG) Prices $125M Subordinated Debentures
by Zacks Equity Research
American Financial's (AFG) new issuance reflects its wise move to capitalize on a low interest rate environment to obtain funds.
eHealth (EHTH) Up 259% in a Year: What's Driving the Stock?
by Zacks Equity Research
Shares of eHealth (EHTH) is expected to continue the bull run backed by solid fundamentals and initiatives to ramp up growth.
What Makes Allstate (ALL) an Attractive Investment Option
by Zacks Equity Research
Allstate (ALL) is poised to grow on the back of its strong property and liability segment, robust balance sheet, brisk service business, higher investment income and prudent capital management.
4 Property & Casualty Insurers Likely to Outperform in Q1
by Tanuka De
We have zeroed in on four P&C insurers that have the potential to deliver solid first-quarter results, backed by prudent underwriting and core strength.
Assurant (AIZ) Gains 15% in a Year: Will the Rally Continue?
by Zacks Equity Research
Shares of Assurant (AIZ) is expected to continue the bull run backed by solid fundamentals and initiatives to ramp up growth.
Horace Mann (HMN) Rewards Shareholders With 1% Dividend Hike
by Zacks Equity Research
Horace Mann's (HMN) 1% dividend hike to add shareholder value will buoy investors' optimism on the stock.